Interferon Newsletter December 2012

Interferon Newsletter

December 2012

Interferon@nature.com subject page hosts a collection of interferon-related original research articles, reviews and commentaries published by the Nature Publishing Group. Sign up for monthly e-alert from Interferon@nature.com

Highlighted articles Access these articles for FREE by visiting Interferon@nature.com   Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β FREE Bibhuti B Mishra, Vijay A K Rathinam, Gregory W Martens, Amanda J Martinot, Hardy Kornfeld, Katherine A Fitzgerald & Christopher M Sassetti Nature Immunology doi:10.1038/ni.2474   Medical therapies for hepatocellular carcinoma: a critical view of the evidence FREE Augusto Villanueva, Virginia Hernandez-Gea & Josep M. Llovet Nature Reviews Gastroenterology & Hepatology doi:10.1038/nrgastro.2012.199   B cells and antibodies in multiple sclerosis pathogenesis and therapy FREE Markus Krumbholz, Tobias Derfuss, Reinhard Hohlfeld & Edgar Meinl Nature Reviews Neurology doi:10.1038/nrneurol.2012.203   Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses FREE S Bhattacharya, W-C HuangFu, G Dong, J Qian, D P Baker, J Karar, C Koumenis, J A Diehl & S Y Fuchs Oncogene doi:10.1038/onc.2012.439 NPG journal-based collections of interest   Systemic Lupus Erythematosus and Type I interferon   Signaling in the Type I Interferon Antiviral Innate Immune Response Recent articles from NPG Access these articles by visiting Interferon@nature.com   The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response Kislay Parvatiyar, Zhiqiang Zhang, Rosane M Teles, Songying Ouyang, Yan Jiang, Shankar S Iyer, Shivam A Zaver, Mirjam Schenk, Shang Zeng, Wenwan Zhong, Zhi-Jie Liu, Robert L Modlin, Yong-jun Liu & Genhong Cheng Nature Immunology doi:10.1038/ni.2460   Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3- and viral-induced expression of type I interferons Jakub Siednienko, Ruaidhri Jackson, Mark Mellett, Nezira Delagic, Shuo Yang, Bingwei Wang, Lisa S Tang, John J Callanan, Bernard P Mahon & Paul N Moynagh "Nature Immunology doi:10.1038/ni.2429   Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver N Obeng-Adjei, D K Choo, J Saini, J Yan, P Pankhong, A Parikh, J S Chu & D B Weiner Cancer Gene Therapy doi:10.1038/cgt.2012.61   Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma X Wang, P Liu, H Liu, W Yang, Z Liu, Z Zhuo & Y Gao Cancer Gene Therapy doi:10.1038/cgt.2012.65   Hepatitis: HCV virologic response–new nomenclature recommendations Stanislas Pol Nature Reviews Gastroenterology & Hepatology doi:10.1038/nrgastro.2012.164   Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium Nirmal Robinson, Scott McComb, Rebecca Mulligan, Renu Dudani, Lakshmi Krishnan & Subash Sad Nature Immunology doi:10.1038/ni.2397

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 4 Crinan Street | London | N1 9XW | UK Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Copyright Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.